Priva Inc.

Priva Inc.

August 15, 2007 11:59 ET

Priva Releases 2nd Quarter Financial Results

MONTREAL, QUEBEC--(Marketwire - Aug. 15, 2007) - Mr. David Horowitz, President and CEO of Priva Inc. (TSX VENTURE:PIV) announced the results for the second Quarter 2007 ended June 30, 2007. Net sales were $2,294,668, a decrease of 42.7% compared with $4,005,849 for the same period ended June 30, 2006. The decrease in sales was directly attributable to the sale of Priva (USA) Inc. on January, 16, 2007.

Gross profit amounted to $594,345, or 25.9% of sales compared with $1,079,400 or 26.9% of sales for the 2nd Quarter of 2006. Priva Inc. reported a consolidated loss of $32,376, or $0.002 per share on a diluted basis for the Quarter ended June 30th, 2007 compared with a loss of $156,076, or $0.009 per share on a fully diluted basis for the same period in the 2nd Quarter 2006. A full copy of the Financial Statements can be viewed on SEDAR at

"We have improved our performance in the 2nd quarter of 2007, especially compared with the first Quarter of 2007. We achieved an increase of 2% in gross margin and a decrease of 25% in Selling and Administrative expenses. We believe that the improvements will continue. Also, near the end of the second quarter of 2007, we received and shipped our first order from Rite Aid Drugs, the third largest drugstore chain in the USA. The initial order was for one product to be sold through approximately 3,500 stores", stated David Horowitz.

Montreal based Priva Inc. is a leading manufacturer, distributor and marketer of an assortment of absorbent, waterproof textile products sold to retailers in Canada, the U.S., the U.K., Australia and New Zealand, with export sales representing just about 60% of sales. Priva's products for adults are sold under the Priva and Americare™ labels; children's products are marketed under the "Snoozy™" and "Tidy Turtle™" brand names and Priva's anti-allergen products are sold under the Quorum™ and Zip & Block™ labels.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Contact Information